V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10341442 | 10039961 | 1.66 | 92 | null | 2018-08-16 | 2018-08-31 | Sunitinib | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101202632 |
| 10341610 | 10039962 | 1.83 | 71 | null | 2021-12-06 | 2021-12-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100721981 |
| 10341971 | 10039963 | 1.75 | 70 | Adjuvant (A) | 2020-02-07 | 2020-02-07 | CISPLATIN + VINORELBINE | 02 | null | SUNITINIB | 100560543 |
| 10342041 | 10039966 | null | null | Curative (C) | 2019-09-27 | 2019-09-28 | Pazopanib | 02 | N | PAZOPANIB | 100515927 |
| 10342062 | 10039967 | 1.62 | 79.9 | Neo-adjuvant (N) | 2016-10-12 | 2016-10-19 | Pazopanib | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100113506 |
| 10342685 | 10039970 | 1.53 | 100.1 | Palliative (P) | null | 2019-12-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100342117 |
| 10342715 | 10039971 | 1.65 | null | Neo-adjuvant (N) | 2018-07-26 | 2018-08-11 | DABRAFENIB + TRAMETINIB | N | N | SUNITINIB | 100965197 |
| 10342761 | 10039972 | 1.67 | 1 | Palliative (P) | 2017-08-29 | 2017-09-06 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101227589 |
| 10343318 | 10039973 | 1.71 | 73.7 | Adjuvant (A) | 2016-06-27 | 2016-06-27 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101271776 |
| 10343539 | 10039974 | 1.75 | 83.6 | null | null | 2019-04-22 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101651337 |
| 10343810 | 10039976 | 1.57 | 80 | Curative (C) | null | 2020-12-16 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100932909 |
| 10343942 | 10039977 | 1.81 | 63 | Adjuvant (A) | 2016-01-06 | 2016-01-06 | CARBOPLATIN + VINORELBINE + RT | 02 | N | CARBOPLATIN + VINORELBINE | 100348848 |
| 10344121 | 10039978 | 0 | 0 | Palliative (P) | 2019-09-25 | 2019-09-29 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100142751 |
| 10344277 | 10039979 | 1.63 | 87 | Curative (C) | 2019-10-15 | 2019-10-15 | Venetoclax | 02 | N | CAPECITABINE + CISPLATIN | 100030070 |
| 10344555 | 10039980 | 1.77 | 64.7 | 02 | 2020-03-06 | 2020-03-16 | Gemcitabine + Capecitabine | 2 | N | CLADRIBINE | 101657456 |
| 10344617 | 10039981 | 1.74 | null | Palliative (P) | 2021-06-12 | 2021-06-12 | BUSULFAN | 02 | null | CISPLATIN + VINORELBINE | 101711570 |
| 10344706 | 10039983 | 1.7 | 50 | Palliative (P) | null | 2021-10-31 | Sunitinib | null | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100229239 |
| 10344794 | 10039984 | 1.58 | 73.8 | null | 2020-07-05 | 2020-07-05 | Cyclophosphamide + Dex + Rituximab | null | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101238011 |
| 10344832 | 10039985 | 1.8 | 88 | Palliative (P) | 2017-03-03 | 2017-03-16 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101849123 |
| 10344995 | 10039986 | 1.77 | 75.8 | Palliative (P) | 2017-04-05 | 2018-10-01 | IRINOTECAN + MDG | 02 | N | FLUOROURACIL + IRINOTECAN | 100687509 |
| 10344996 | 10039987 | 1.6 | null | null | 2018-01-12 | 2018-01-24 | FEC 100 | N | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101051326 |
| 10345100 | 10039988 | 1.56 | 102.7 | Palliative (P) | null | 2020-08-30 | CISPLATIN + FLUOROURACIL | 02 | N | PAZOPANIB | 100052207 |
| 10345183 | 10039989 | 1.8 | 81 | null | 2020-01-06 | 2020-01-22 | POMALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101118914 |
| 10345985 | 10039990 | 1.91 | 62 | Neo-adjuvant (N) | 2019-07-03 | 2019-07-14 | CHOP R | 02 | null | CHOP R | 101854550 |
| 10346155 | 10039991 | 1.8 | 77.2 | Curative (C) | 2019-04-29 | 2019-04-29 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101144118 |
| 10346222 | 10039992 | null | null | Adjuvant (A) | 2018-05-14 | 2018-05-17 | DARATUMUMAB | 02 | N | CYTARABINE | 100744387 |
| 10346925 | 10039993 | 1.75 | 66.4 | null | 2020-04-15 | 2020-05-06 | null | 02 | null | VENETOCLAX | 100995912 |
| 10347095 | 10039994 | 1.81 | 94.6 | Palliative (P) | 2018-07-29 | 2018-08-12 | BCG Intravesical | 02 | null | CLADRIBINE | 101486996 |
| 10347359 | 10039995 | 1.7 | 0 | null | 2018-02-19 | 2018-02-28 | null | 02 | null | MITOMYCIN | 100215681 |
| 10347427 | 10039996 | 1.76 | null | 03 | 2018-02-09 | 2018-02-17 | Cytarabine Low Dose | 02 | N | BUSULFAN | 100066603 |
| 10347573 | 10039997 | 1.7 | 80 | null | 2019-05-19 | 2019-05-19 | CAPECITABINE + GEMCITABINE | 02 | null | BUSULFAN | 101175252 |
| 10347599 | 10039998 | null | null | null | 2021-12-25 | 2021-12-30 | BORTEZOMIB + THALIDOMIDE | 2 | null | BORTEZOMIB + THALIDOMIDE | 101689182 |
| 10347790 | 10039999 | 1.6 | 78.8 | 03 | 2019-11-14 | 2019-11-20 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100122337 |
| 10348271 | 10040001 | 1.65 | 60.3 | Adjuvant (A) | 2017-09-27 | 2017-09-27 | Cytarabine Low Dose | 02 | null | TRIAL | 100737160 |
| 10348764 | 10040002 | 1.79 | 89 | Curative (C) | 2021-12-08 | 2021-12-08 | CLADRIBINE | 02 | Y | CLADRIBINE | 100430393 |
| 10348770 | 10040003 | 1.7 | 0 | 03 | 2018-01-31 | 2018-02-02 | Folfirinox/ Folfoxiri | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101260951 |
| 10349148 | 10040005 | 1.82 | 81 | Adjuvant (A) | 2018-01-29 | 2018-02-12 | POMALIDOMIDE | 02 | N | CVP R | 101200894 |
| 10349266 | 10040006 | 1.64 | 67.5 | Palliative (P) | 2018-09-18 | 2018-10-04 | Cyclophosphamide + Dex + Rituximab | 02 | N | BCG | 101278660 |
| 10350105 | 10040007 | 1.65 | 80.7 | Palliative (P) | 2019-08-23 | 2019-08-30 | Avelumab | 02 | null | AVELUMAB | 100819108 |
| 10350156 | 10040008 | 1.62 | 77.4 | null | 2019-02-24 | 2019-02-24 | Sunitinib | null | N | POMALIDOMIDE | 101707494 |
| 10350487 | 10040011 | 1.76 | 91 | Palliative (P) | 2022-02-05 | 2022-02-10 | DABRAFENIB + TRAMETINIB | N | N | CAPECITABINE + GEMCITABINE | 101142372 |
| 10350641 | 10040012 | 1.8 | 98.15 | Adjuvant (A) | 2018-11-04 | 2018-11-04 | Palbociclib | 02 | N | PALBOCICLIB | 100507959 |
| 10351007 | 10040014 | 1.5 | 73 | Palliative (P) | 2021-07-14 | 2021-07-18 | Cyclophosphamide + Dex + Rituximab | 02 | N | DARATUMUMAB | 100336095 |
| 10351550 | 10040017 | 1.78 | 62.8 | 03 | 2021-12-23 | 2021-12-23 | Cisplatin + Vinorelbine (PO) | N | N | MITOMYCIN | 100945888 |
| 10351668 | 10040018 | 1.7 | 65 | Palliative (P) | 2017-07-17 | 2017-07-17 | null | 02 | N | PAZOPANIB | 101191506 |
| 10351948 | 10040019 | 1.83 | 83 | Adjuvant (A) | 2018-03-07 | 2018-03-13 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100329009 |
| 10352108 | 10040020 | 1.71 | 55.6 | Neo-adjuvant (N) | 2022-01-16 | 2022-01-16 | Trial Unspecified | 02 | N | VENETOCLAX | 101438855 |
| 10352452 | 10040021 | 1.64 | 86 | 03 | 2019-12-22 | 2019-12-27 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101294264 |
| 10352553 | 10040022 | 1.8 | 79.7 | null | 2018-07-26 | 2018-08-15 | DARATUMUMAB | 02 | null | CAPECITABINE + GEMCITABINE | 101403317 |
| 10353608 | 10040024 | 1.8 | 94 | Curative (C) | 2018-11-28 | 2018-12-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101678942 |